1. Home
  2. Analysis
  3. Trasylol
  4. Hypoxic-ischaemic-encephalopathy

Trasylol and Hypoxic-ischaemic encephalopathy - a phase IV clinical study of FDA data

Summary:

Hypoxic-ischaemic encephalopathy is reported as a side effect among people who take Trasylol (aprotinin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Heparin,.

The phase IV clinical study analyzes which people have Hypoxic-ischaemic encephalopathy when taking Trasylol. It is created by eHealthMe based on reports of 9,460 people who have side effects when taking Trasylol from the FDA, and is updated regularly.

What is Trasylol?

Trasylol has active ingredients of aprotinin. eHealthMe is studying from 9,460 Trasylol users. Check the latest studies of Trasylol.

What is Hypoxic-ischaemic encephalopathy?

Hypoxic-ischaemic encephalopathy (a condition that occurs when the entire brain is deprived of an adequate oxygen supply, but the deprivation isn't total) is found to be associated with 371 drugs and 600 conditions by eHealthMe. Check the latest studies of Hypoxic-ischaemic encephalopathy.

On Jul, 28, 2026

9,460 people reported to have side effects when taking Trasylol.
Among them, 11 people (0.12%) have Hypoxic-ischaemic encephalopathy.

Could Trasylol cause Hypoxic-ischaemic encephalopathy?

Among these 11 people:

How long have people been on Trasylol when they have Hypoxic-ischaemic encephalopathy? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Hypoxic-ischaemic encephalopathy when taking Trasylol? *

  • female: 27.27 %
  • male: 72.73 %

What is the age of people who have Hypoxic-ischaemic encephalopathy when taking Trasylol? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 9.09 %
  • 50-59: 27.27 %
  • 60+: 63.64 %

What are other drugs people take besides Trasylol? *

  1. Heparin: 9 people, 81.82%
  2. Lasix: 5 people, 45.45%
  3. Nitroglycerin: 4 people, 36.36%
  4. Fentanyl: 3 people, 27.27%
  5. Lipitor: 3 people, 27.27%
  6. Aspirin: 3 people, 27.27%
  7. Plavix: 3 people, 27.27%
  8. Protamine Sulfate: 3 people, 27.27%
  9. Protonix: 2 people, 18.18%
  10. Fosamax: 2 people, 18.18%

What are other side effects people have besides Hypoxic-ischaemic encephalopathy? *

  1. Acute Kidney Failure: 9 people, 81.82%
  2. Injury: 9 people, 81.82%
  3. Emotional Distress: 8 people, 72.73%
  4. Pain: 8 people, 72.73%
  5. Stress And Anxiety: 8 people, 72.73%
  6. Fear: 6 people, 54.55%
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable): 5 people, 45.45%
  8. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 4 people, 36.36%
  9. Depression: 4 people, 36.36%
  10. Death: 4 people, 36.36%

* Approximation only. Some reports may have incomplete information.

Do you take Trasylol and have Hypoxic-ischaemic encephalopathy?

- Check whether Hypoxic-ischaemic encephalopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Trasylol:

Hypoxic-ischaemic encephalopathy treatments and more:

How severe was Hypoxic-ischaemic encephalopathy and when was it recovered:

Expand to all the drugs that have ingredients of aprotinin:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Trasylol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypoxic-ischaemic encephalopathy:

Browse all the conditions that are associated with Hypoxic-ischaemic encephalopathy:

How the study uses the data?

The study uses data from the FDA. It is based on aprotinin (the active ingredients of Trasylol) and Trasylol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.